Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea · Delayed Price · Currency is KRW

6,460.00

+260.00 (4.19%)

Aug 3, 2026, 3:30 PM KST

KRX:000520 Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	210,513	210,253	219,700	196,346	179,676	134,247
Revenue Growth	-3.30%	-4.30%	11.89%	9.28%	33.84%	9.14%
Gross Profit	75,746	77,118	80,914	74,071	67,486	48,988
Operating Income	-26,937	-23,938	48.11	6,460	4,017	399.74
Net Income	-36,417	-34,664	-5,629	1,664	-28.29	-5,347
Earnings Per Share	-1714.26	-1633.00	-313.00	115.00	-2.03	-386.63
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
South Korea	209,592	209,588	217,521	194,926	178,833	133,732
Export	921.12	665.37	2,179	1,420	842.66	514.49
Total	210,513	210,253	219,700	196,346	179,676	134,247

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,188	6,412	5,137	906.14	1,903	15,261
Total Debt	166,026	164,023	150,081	175,879	159,258	125,515
Net Cash (Debt)	-164,838	-157,611	-144,944	-174,973	-157,355	-110,254
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7758.64	-7424.11	-8059.84	-12095.82	-11286.13	-7972.68

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	11,040	568.16	2,590	11,746	4,154	1,417
Capital Expenditures	-10,154	-7,457	-5,372	-24,244	-48,481	-32,828
Free Cash Flow	886.22	-6,888	-2,782	-12,498	-44,327	-31,411
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	35.98%	36.68%	36.83%	37.72%	37.56%	36.49%
Operating Margin	-12.80%	-11.39%	0.02%	3.29%	2.23%	0.30%
Pretax Margin	-18.64%	-17.67%	-1.64%	0.73%	0.59%	-3.55%
Profit Margin	-17.30%	-16.49%	-2.56%	0.85%	-0.02%	-3.98%
FCF Margin	0.42%	-3.28%	-1.27%	-6.37%	-24.67%	-23.40%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	58.25	-	-
PS Ratio	0.66	0.98	1.27	0.49	0.61	0.79